Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study

INTRODUCTION: Interstitial lung disease (ILD) is a common extra-articular condition in rheumatoid arthritis (RA), but few studies have systematically investigated its incidence and risk factors in patients receiving anti-tumor necrosis factor-alpha (anti-TNFα) agents or alternate mechanisms of actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Sarsour, Khaled, Napalkov, Pavel, Costa, Laurie A., Schulman, Kathy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641344/
https://www.ncbi.nlm.nih.gov/pubmed/26555431
http://dx.doi.org/10.1186/s13075-015-0835-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641344/
https://www.ncbi.nlm.nih.gov/pubmed/26555431
http://dx.doi.org/10.1186/s13075-015-0835-7

Ejemplares similares